Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-1,974
Closed -$268K – 194
2023
Q2
$268K Buy
+1,974
New +$241K 0.07% 154
2022
Q3
– Sell
-1,637
Closed -$157K – 234
2022
Q2
$157K Sell
1,637
-146
-8% -$17.5K 0.05% 201
2022
Q1
$265K Hold
1,783
– – 0.08% 151
2021
Q4
$253K Hold
1,783
– – 0.11% 162
2021
Q3
$233K Hold
1,783
– – 0.11% 154
2021
Q2
$245K Buy
1,783
+134
+8% +$18.3K 0.12% 148
2021
Q1
$215K Buy
1,649
+491
+42% +$59.1K 0.11% 156
2020
Q4
$130K Buy
1,158
+263
+29% +$24.9K 0.08% 176
2020
Q3
$70K Buy
+895
New +$73K 0.05% 216

Other funds holding CNMD

First Bank & Trust's CNMD Position: Q3 2023 in Review

First Bank & Trust sold out of CONMED (CNMD) in Q3 2023, closing a stake of 1,974 shares — an estimated $268K sold.

First Bank & Trust first reported a position in CNMD in Q3 2020 and held it in 9 quarters. The position peaked at $268K in Q2 2023. 274 funds tracked by Wall St. Rank hold CNMD as of Q3 2023.

  • First Bank & Trust reported no remaining CONMED position as of Q3 2023 after selling out during the quarter.
  • First Bank & Trust sold 1,974 CONMED shares in Q3 2023, an estimated $268K.
  • First Bank & Trust first reported a position in CONMED in Q3 2020 and held it in 9 quarters.
  • First Bank & Trust's CONMED position peaked at $268K in Q2 2023.
  • 274 funds tracked by Wall St. Rank held CONMED as of Q3 2023.

Based on First Bank & Trust's 13F filing for Q3 2023, filed 11 Oct 2023.